SK Biopharmaceuticals Co., Ltd. (KRX:326030)

SK Biopharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,207,229	8,700,602	7,862,650	5,646,385	7,612,048	13,234,939
Market Cap Growth	10.66%	10.66%	39.25%	-25.82%	-42.48%	-
Enterprise Value	8,094,933	8,637,734	7,807,605	5,442,304	7,267,516	12,840,764
Last Close Price	104800.00	111100.00	100400.00	72100.00	97200.00	169000.00
PE Ratio	34.09	36.14	-	-	117.39	-
Forward PE	55.85	73.81	-	-	-	-
PS Ratio	14.99	15.89	22.16	22.94	18.18	509.06
PB Ratio	14.30	15.16	24.50	17.84	17.14	34.92
P/TBV Ratio	15.32	16.24	29.59	18.86	17.90	36.83
P/FCF Ratio	87.77	93.05	-	-	-	-
P/OCF Ratio	86.48	91.68	-	-	-	-
EV/Sales Ratio	14.78	15.77	22.00	22.11	17.36	493.89
EV/EBITDA Ratio	98.10	75.93	-	-	68.18	-
EV/EBIT Ratio	124.37	89.66	-	-	76.53	-
EV/FCF Ratio	86.57	92.38	-	-	-	-
Debt / Equity Ratio	0.32	0.32	0.56	0.49	0.04	0.05
Debt / EBITDA Ratio	1.62	1.62	-	-	0.15	-
Debt / FCF Ratio	1.97	1.97	-	-	-	-
Asset Turnover	0.62	0.62	0.51	0.38	0.73	0.08
Inventory Turnover	0.40	0.40	0.35	0.53	0.60	0.13
Quick Ratio	1.26	1.26	1.47	2.28	2.64	5.67
Current Ratio	1.64	1.64	2.02	2.99	3.18	6.16
Return on Equity (ROE)	50.72%	50.72%	-11.10%	-36.66%	15.75%	-135.18%
Return on Assets (ROA)	6.84%	6.84%	-3.38%	-12.53%	10.38%	-46.83%
Return on Capital (ROIC)	9.58%	9.58%	-4.83%	-17.57%	13.84%	-60.65%
Return on Capital Employed (ROCE)	15.00%	15.00%	-	-	19.20%	-
Earnings Yield	293.32%	2.77%	-0.42%	-2.47%	0.85%	-1.87%
FCF Yield	113.93%	1.07%	-1.23%	-2.92%	-1.28%	-1.68%
Buyback Yield / Dilution	-	-	-	-	-9.12%	-10.41%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.